Janus Henderson Group Plc - Dec 31, 2024 SCHEDULE 13G Report for Entrada Therapeutics, Inc. Common Stock (TRDA)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
Entrada Therapeutics, Inc. Common Stock
Symbol
TRDA
Shares outstanding
37.1M shares
Disclosed Ownership
2.08M shares
Ownership
5.6%
Form type
SCHEDULE 13G
Date filed
2/14/2025, 11:25 AM
Date of event
Dec 31, 2024
Next filing
May 14, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 5.6% 2.08M 0 2.08M Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 5% 1.88M 0 1.88M Kristin Mariani Head of North America Compliance, CCO